Invictus MD Strategies (
CSE: IMH,
Stock Forum) lived up to its name when the company announced today that it had appointed George Edward Kveton to its advisory board.
According to the
news release, Kveton, already an investor in the company, has broad experience in operating and influencing at the C-suite level and a proven track record in generating top-line growth by executing cross-border acquisitions valued up to $1.0 billion, transformations to a high standard and in developing new profit streams in regulated sectors.
An extremely effective, strategic and practical international executive and investment professional, Kveton brings over two decades of experience to the table with a storied background working for top tobacco manufacturers.
Company CEO, Dan Kriznic, commented on the appointment and its worth to the company, “George brings over 20 years of strategy and corporate development experience. He has worked with leading tobacco players possessing enviable financial firepower (EBITDA in the $5 to 15 billion range), in addition to fast moving consumer goods and big consultancy companies.”
He went on to illustrate, “His deal sheets are international, spanning Africa, the Middle East, Europe, Asia and North and South America, as well as start-up venture expertise, complemented by an impressive network built with the global investment banking community.”
Then he concluded, “On behalf of the team at Invictus MD we want to welcome George to the Advisory Board.”
Invictus MD Strategies was in the news recently when
the Vancouver-based company announced closing the first tranche of its recently announced private placement offering.
Shares gained 3.33% on the news to $0.155 per share.
Currently there are 42.0m outstanding shares with a market cap of $6.5 million.
FULL DISCLOSURE: Invictus MD Strategies is a Stockhouse Publishing client